Dr. Seth Allen Rosenthal, MD

Dr. Rosenthal practices at Sutter Imaging Roseville II in Roseville, California.

Dr. Rosenthal's NPI, 1881690584, was assigned on June 27, 2005. Dr. Rosenthal graduated from Yale School of Medicine in 1987. Dr. Rosenthal holds California license G71038.

Dr. Rosenthal's primary practice is Sutter Imaging Roseville II, at 2 Medical Plaza Ste 105, Roseville, CA 95661. The practice phone is (916) 865-1469.

Dr. Rosenthal's primary practice is Sutter Imaging Roseville II in Roseville, California. Dr. Rosenthal is also affiliated with Sutter Roseville Medical Center. The medical group on file is SGMF Radiology. Dmand AI also links Dr. Rosenthal to 1 more group practice or clinic, named with a free account. Dr. Rosenthal's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rosenthal practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Rosenthal's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Rosenthal is board certified in hospice and palliative medicine by the American Board of Internal Medicine. Dmand AI has Dr. Rosenthal's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, lung cancer radiation and lymphoma radiation among the conditions Dr. Rosenthal treats.

CMS data shows 4,892 Medicare services from Dr. Rosenthal across 21 procedure codes in 2024, for 311 Medicare patients. Medicare paid $857,923 for them. Every service was in an office.

CMS counts 311 Medicare patients who saw Dr. Rosenthal in 2024. The largest group is 75 to 84, with 129 patients. 75% of them have cancer, and 75% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rosenthal's median patient age at 74, with 36% women.

In 2024, Dr. Rosenthal wrote 189 Medicare Part D claims for 65 patients. 97% of them were for generic drugs. CMS names the drug for 168 of them, across 3 drugs with 11 or more claims each, at $2,481 in total drug cost. In 2023, CMS named 141 claims across 3 drugs.

Dr. Rosenthal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 96 papers to Dr. Rosenthal, published from 2006 to 2024. 2018 was the busiest year, with 9. The most frequent topics are Prostatic Neoplasms, Radiation Oncology and Androgen Antagonists. Dr. Rosenthal has published most often in Int J Radiat Oncol Biol Phys. Dr. Rosenthal's most frequent co-authors are Howard M. Sandler, MD, Alan C. Hartford, MD, PhD and Eric Mark Horwitz, MD.

Dmand AI links Dr. Rosenthal to 2 clinical trials, 2 of them phase 3 studies. Conditions studied include Prostatic Neoplasms and Prostatic Diseases. Radiation Therapy Oncology Group sponsors the most, 2.

CMS Open Payments shows 18 general payments to Dr. Rosenthal from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Siemens Medical Solutions USA, Inc. paid the most, $468.

Dmand AI lists 1 award for Dr. Rosenthal, most recently CMS Stage 1 EHR in 2012.

Dr. Rosenthal graduated from Yale School of Medicine in 1987.

Dr. Rosenthal is in network with 12 carriers, including Elevance, United Healthcare and Aetna. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.